TriSalus Life Sciences, Inc.
USD4.74
+0.01 (+0.21%)
CEO
Mary T. Szela
IPO Date
2021-02-08
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$4.73
Prev. Close
$4.73
Day Low
$4.59
Day High
$4.84
52W Low
$2.20
52W High
$7.95
Market Cap
$0.18B
Volume
0.29M
| -4.0 |
| 31 Dec 2023 | FY | 85.9% | -320.7% | 219.3% | -241.3% | -0.06 | 1.42 | -3.8 |
| 31 Dec 2022 | FY | 81.8% | -380.6% | 382.9% | -214.5% | -0.16 | 0.53 | -6.3 |
| 31 Dec 2021 | FY | 85.8% | -343.4% | -93.3% | -76.2% | 0.00 | 5.51 | -10.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 63.5% | -391.6% | -0.84 | 0.11 | -10.1 |
| -8.4 |
| 30 Sept 2025 | Q3 | 83.5% | -93.5% | 40.5% | -29.6% | -1.28 | 3.05 | -4.6 |
| 30 Jun 2025 | Q2 | 83.9% | -73.9% | 42.7% | -20.1% | -1.73 | 4.08 | -5.4 |
| 31 Mar 2025 | Q1 | 83.7% | -113.2% | 30.2% | -36.2% | -0.96 | 2.14 | -3.8 |
| 31 Dec 2024 | Q4 | 85.3% | -122.4% | 39.0% | -42.2% | -0.91 | 2.02 | -3.3 |
| 30 Sept 2024 | Q3 | 86.3% | -32.6% | 11.7% | -8.7% | -1.15 | 2.40 | -12.7 |
| 30 Jun 2024 | Q2 | 87.6% | -58.8% | 17.9% | -13.4% | -0.94 | 2.33 | -7.4 |
| 31 Mar 2024 | Q1 | 85.0% | -204.7% | 37.9% | -73.9% | -0.05 | 0.92 | -4.5 |
| 31 Dec 2023 | Q4 | 89.8% | -620.7% | 131.2% | -144.4% | -0.06 | 1.42 | -1.6 |